The research, carried out at the Kobo research sub-center under artificially infested field conditions, represents a systematic effort to quantify how different sorghum lines respond to Striga pressure while simultaneously maintaining agronomic performance. Sorghum, a staple food for over 300 million people in Africa, ranks fifth globally in cultivated area with 58 million hectares and sixth in production at 63.9 million metric tons. Ethiopia stands among the world’s top ten sorghum producers and is the third-largest producer on the African continent, yet the national average grain output of 2.7 tons per hectare remains constrained by a combination of drought and parasitic weed pressure, particularly in the northern and northeastern regions of the country.

The experimental design was rigorous and deliberate. Forty-nine sorghum genotypes, including susceptible and resistant checks obtained from the Melkasa Agricultural Research Center, were arranged in a 7 by 7 simple lattice design. Each genotype was planted on plots consisting of two rows of 3 meters in length with 0.75 meters between rows, covering a plot area of 4.5 square meters. Every planting plot was artificially infested with 5 grams of Striga hermonthica seeds collected in 2021 from heavily infested sorghum fields in the Kobo, Habru, and Dawa Chefa districts. The genotypes themselves were products of crossing programs that paired pure lines and early maturing varieties as female parents with Striga-resistant varieties including Framida, Gobiye, and Birehan as male parents, creating a diverse genetic pool for evaluation.

The results of the analysis of variance revealed highly significant differences among the tested genotypes across virtually all measured traits, including days to flowering, days to maturity, plant height, panicle length, panicle width, head count, head weight, biomass weight, grain yield, thousand kernel weight, harvest index, Striga count, and Striga severity. This breadth of variation signals ample genetic variability that breeders can exploit. Plant height alone ranged from 136 centimeters in the standard check Gobiye to 338 centimeters in genotype ETSC17028, while Striga count and severity varied from 0.57 to 22.07 and from 1.4 to 58, respectively. Grain yields spanned from a low of 2.5 tons per hectare in genotype ETSC17065-2 to a high of 6.5 tons per hectare in ETSC17096-2, demonstrating the enormous productive potential locked within the genetic diversity of the tested materials.

The correlation analysis between grain yield and Striga-related traits produced some of the most striking findings of the study. At the genotypic level, grain yield showed highly significant positive correlations with panicle length (0.68), head count (0.83), head weight (0.95), biomass yield (0.77), and harvest index (0.8). Conversely, grain yield was highly significantly and negatively correlated with Striga count (-0.9 at the phenotypic level and -0.94 at the genotypic level), Striga vigorosity (-0.24 and -0.36), and Striga severity (-0.89 and -0.93). These coefficients tell a clear biological story: the more Striga plants that emerge and the more severe the infestation, the lower the grain yield. The genotypic correlation values generally exceeded their phenotypic counterparts, suggesting that the underlying genetic associations between these traits are even stronger than what field observations alone reveal, a critical insight for selection strategy in breeding programs.

Principal component analysis further illuminated the structure of variation among the 49 genotypes. The first five principal components collectively explained 86.8 percent of the total variation, with the first component alone accounting for 48.19 percent. Traits loading heavily on the first component included head count (0.32), head weight (0.37), biomass yield (0.33), grain yield (0.38), and harvest index (0.32), while Striga count and Striga severity both carried negative loadings of -0.36. The second component, explaining 14.16 percent of the variation, was dominated by days to flowering (0.55), days to maturity (0.59), and plant height (0.46), while panicle width (0.76) was the most significant contributor to the third component. This multivariate picture confirms that no single trait can capture the full spectrum of variation among sorghum genotypes, underscoring the need for integrated selection approaches that consider multiple characteristics simultaneously.

Cluster analysis using Mahalanobis’s D2 statistic grouped the 49 genotypes into five distinct clusters, each with characteristic profiles of performance and Striga response. Cluster I was the largest, containing 20 genotypes, followed by Cluster II with 16, Cluster III with 10, Cluster IV with 2, and Cluster V with just 1. Cluster III emerged as the standout group, characterized by the highest plant height (287.2 centimeters), the longest panicles (35.6 centimeters), the largest head count (41), the heaviest head weight (8.2 tons per hectare), the highest biomass yield (18 tons per hectare), and the highest grain yield (6.04 tons per hectare). Critically, Cluster III also recorded the lowest Striga count (3.2) and the lowest Striga severity (7.9), making it a treasure trove of resistance alleles for future breeding. In stark contrast, Clusters II and IV harbored the most susceptible genotypes, with Striga severity scores of 48.2 and 50.9 respectively and correspondingly depressed grain yields of 3.2 and 2.8 tons per hectare.

The inter-cluster distances revealed the genetic architecture underlying these groupings. The maximum distance was observed between Cluster III and Cluster V (666.2), followed by Cluster II and Cluster V (561.6) and Cluster I and Cluster V (552.3). These large distances suggest that crosses between parents drawn from these maximally divergent clusters would likely produce the greatest heterosis, or hybrid vigor, in subsequent generations. Conversely, the shortest inter-cluster distance was found between Cluster II and Cluster IV (18.2), indicating that genotypes within these groups are genetically similar and crossing them would yield limited variability in segregating populations. The chi-square distribution test confirmed significant genotypic differences between clusters, reinforcing the utility of divergence analysis as a prerequisite step before any hybridization program begins, saving breeders time and resources by directing crosses toward genetically complementary parents.

Among the individual genotypes, ten stood out as Striga-resistant, having achieved the highest mean grain yields and the lowest mean Striga severity scores, outperforming even the resistant check Gobiye. These included ETSC17008-1, ETSC17016-1, ETSC17096-2, ETSC17009-1, ETSC17023-2, ETSC17028-1, ETSC17117-2, ETSC17090-1, ETSC17103-1, and ETSC17048-1. Thirteen additional genotypes showed better grain yield with moderate Striga counts and severity, placing them in an intermediate tolerance category, while the remaining twenty-four were classified as susceptible due to their low grain production, high emerging Striga counts, and high Striga severity. The resistant check Gobiye itself recorded 5 Striga plants per square meter with a severity of 12.1 and a grain yield of 5.1 tons per hectare, while the susceptible local check Jigurite carried a mean Striga count of 19.8 with a severity of 52.43 and a grain yield of only 3 tons per hectare, providing clear benchmarks against which the experimental lines could be judged.

The implications of this research extend well beyond the borders of the Kobo district. Striga is estimated to threaten the livelihoods of over 100 million people in sub-Saharan Africa and causes annual yield losses valued at approximately 7 billion dollars. In Ethiopia and Sudan, sorghum yield losses attributable to Striga have been reported to range from 65 to 100 percent in heavily infested fields. The identification of resistant genotypes represents the most economical, straightforward, and effective control strategy available to resource-constrained farmers, and the genotypes highlighted in this study, particularly those from Cluster III, offer a ready source of resistance alleles for incorporation into elite breeding lines. As the researchers note, further validation across multiple locations and seasons will be essential, given that Striga expression is heavily influenced by environmental variation, but the foundation has been laid for a new generation of sorghum cultivars that can stand firm against one of agriculture’s most insidious parasites.

Subject of Research: Sorghum genotype resistance to the parasitic weed Striga hermonthica and trait associations for breeding

Article Title: Evaluation of sorghum ( Sorghum bicolor ( l. ) Moench) genotypes for striga resistance and associations among yield and striga related traits

Article References: Evaluation of sorghum ( Sorghum bicolor ( l. ) Moench) genotypes for striga resistance and associations among yield and striga related traits. (n.d.). https://doi.org/10.3897/ia.2025.164256

Image Credits: AI Generated

DOI: 10.3897/ia.2025.164256

Keywords: sorghum, Striga hermonthica, parasitic weed, grain yield, genetic correlation, cluster analysis, principal component analysis, Ethiopia, plant breeding, crop resistance, agronomic traits, food security

The research, led by Solveig Løkhammer and Renato Polimanti of Yale School of Medicine together with colleagues at the University of Bergen and partner institutions across Europe and the United States, harnessed three of the largest biomedical databases in existence: the All of Us Research Program with 98,551 participants, the FinnGen Project with 377,277, and the Million Veteran Program with 449,042. Together these cohorts provided both genome-wide genetic data and longitudinal electronic health records, allowing the team to connect inherited variation with real clinical diagnoses across the human phenome. The scale matters. Childhood maltreatment is difficult to study directly, both because retrospective reports are imperfect and because the environmental and genetic factors that shape families are deeply intertwined. Genetic approaches offer a way to disentangle some of that tangle.

The centerpiece of the study was a phenome-wide association study, or PheWAS, of genetic variants previously linked to childhood maltreatment. Rather than asking whether one variant relates to one disease, a PheWAS flips the design: the researchers took the set of genetic loci associated with maltreatment liability and systematically tested them against thousands of coded medical outcomes in the health records of the three cohorts. The signal was striking. The maltreatment-associated loci showed associations with 66 distinct medical outcomes at a genome-wide significance threshold of p less than 2.76 × 10⁻⁶. The affected domains were broad, spanning psychiatric conditions, musculoskeletal disorders, circulatory disease, neurologic conditions and respiratory illness, suggesting that the genetic architecture of maltreatment risk is woven into many different systems of the body rather than confined to the brain.

To probe those relationships more deeply, the team turned to genetic correlation analysis, which estimates the degree to which two traits share the same underlying genetic influences across the entire genome. Here the picture became even richer: 285 significant genetic correlations with childhood maltreatment emerged at a threshold of p less than 3.24 × 10⁻⁵, again covering a wide range of medical domains. Among all of these, one relationship towered above the rest. Emotional disorders with onset during childhood or adolescence showed the highest genetic overlap with maltreatment liability, with a genetic correlation of 0.75. That figure implies a very substantial sharing of genetic influences between the liability to experience or report maltreatment and the liability to develop early-onset emotional disorders, a finding that resonates with long-standing clinical observations that abuse, anxiety and depression cluster within the same families and the same developmental windows.

Genetic correlation, however, cannot by itself tell us the direction of causation or whether the shared signal reflects a single causal variant or many. The researchers therefore deployed latent causal variable analysis, a method that uses the observed genetic correlations and their standard errors to distinguish genuine causality from confounding due to shared ancestry or overlapping variant effects. The LCV results pointed to genetic relationships between childhood maltreatment and musculoskeletal, metabolic, respiratory and eye-related outcomes, extending the story beyond psychiatry into physical health domains that are rarely discussed in the same breath as early adversity. The suggestion that maltreatment genetic liability travels with conditions affecting bones, joints, metabolism and vision adds a provocative new dimension to the biology of early-life stress.

The next question was whether these genetic relationships behave like causal effects, and the answer turned out to be complicated. Using bidirectional Mendelian randomization, a technique that uses genetic variants as natural instruments to test whether one trait influences another, the team found bidirectional and heterogeneous effects for the outcomes flagged by LCV. In other words, genetic instruments for maltreatment liability appeared to influence these health outcomes, but instruments for the outcomes also appeared to influence maltreatment liability, and the effects were not consistent across instruments. The authors interpret this pattern as possibly reflecting dynastic confounding, a subtle phenomenon in which the genotypes of parents and more distant ancestors shape the family environments into which children are born, blurring the line between inherited biology and inherited circumstance. In studies of parenting and childhood outcomes, dynastic effects are a serious methodological concern, and their presence here cautions against simple causal narratives.

Perhaps the most socially consequential finding came from the final layer of analysis. The researchers asked whether the genetic associations between childhood maltreatment and adult health might actually be carried, at least in part, by socioeconomic conditions, using household income as a proxy. Two complementary methods were applied: multi-trait conditional and joint analysis, which partitions genetic signal among correlated traits, and multivariate Mendelian randomization, which estimates the direct effect of one exposure while accounting for others that share its instruments. Both analyses converged on the same conclusion. When household income was taken into account, the effect of childhood maltreatment genetic liability on health outcomes was reduced. Socioeconomic factors, in other words, appear to explain a meaningful share of what had looked like a direct genetic relationship between early adversity and adult disease.

The authors are careful about what this does and does not mean. The finding does not suggest that maltreatment is benign, nor that its health consequences are illusory. Rather, it indicates that different pleiotropic mechanisms, in which the same genetic variants influence multiple traits, likely contribute to the observed relationships between maltreatment and several health domains, and that these relationships are at least partially explained by the socioeconomic contexts that shape both the risk of maltreatment and the trajectory of health across the life course. Genes, family income, neighborhood, and parenting behavior are not independent variables; they cascade through one another across generations. A study of this design cannot fully separate those strands, but it can measure how much of the apparent genetic signal survives when the socioeconomic strand is held steady, and here the answer is: less than the raw correlations implied.

For the field of trauma research, the study offers both a methodological template and a conceptual warning. The template is the integration of PheWAS, genetic correlation, latent causal variable analysis, and univariate and multivariate Mendelian randomization across multiple biobanks, a pipeline that interrogates the same question from several independent angles and reports where the answers agree and where they fracture. The warning is that observational associations between childhood adversity and adult disease, even those that appear in genetic data, can be shaped by dynastic and socioeconomic confounding in ways that standard adjustments do not capture. Interventions aimed at breaking the intergenerational cycle of maltreatment may need to target economic conditions as directly as they target parenting and mental health, because the two are genetically and environmentally entangled.

What emerges from this investigation is a portrait of childhood maltreatment as a genetically and socially embedded phenomenon whose fingerprints appear across psychiatric, musculoskeletal, circulatory, neurologic, respiratory, metabolic and even ocular health in adulthood. The strongest genetic overlap lies with emotional disorders beginning in childhood and adolescence, reinforcing the idea that the earliest years are a critical window in which liability to adversity and liability to emotional illness travel together. But the attenuation of maltreatment effects after accounting for household income is the finding with the clearest policy resonance: part of the long shadow of early adversity is cast not by biology alone but by the economic circumstances that surround a child. Disentangling those threads, the authors suggest, will require the continued growth of genetically informed cohorts and methods that can separate direct genetic effects from the inherited environments families pass down alongside their DNA.

Subject of Research: Genetic and socioeconomic mechanisms linking childhood maltreatment to adult health outcomes

Article Title: A genetically informed investigation into the relationship between childhood maltreatment and adult health

Article References: A genetically informed investigation into the relationship between childhood maltreatment and adult health. (n.d.). https://doi.org/10.1038/s41398-026-04498-1

Image Credits: AI Generated

DOI: 10.1038/s41398-026-04498-1

Keywords: childhood maltreatment, genetics, PheWAS, Mendelian randomization, genetic correlation, socioeconomic factors, household income, psychiatric disorders, Translational Psychiatry, All of Us, FinnGen, Million Veteran Program

The research team, led by Ruikang Liu, Chiyun Sun and Yonghao Li of Beijing University of Chinese Medicine and the China Academy of Chinese Medical Sciences, together with colleagues at several Chinese hospitals, assembled genome-wide association study (GWAS) summary statistics for heart failure and osteoporosis and subjected them to a battery of complementary statistical tools. Rather than asking whether the two diseases share one or two risk genes, the investigators probed the architecture of the entire genetic landscape: how many variants influence both traits, whether those variants push risk in the same or opposite directions, which genes the signals point to, and where in the body those genes are active.

The first and perhaps most striking finding concerns polygenic overlap. Using MiXeR, a bivariate causal mixture model that estimates the number of genetic variants with non-null effects on each trait, the team calculated that approximately 447 ± 114 variants influence both heart failure and osteoporosis. That shared set corresponds to roughly 52 percent of the estimated non-null variant count for osteoporosis and about 21 percent of that for heart failure. In other words, a substantial fraction of the genetic determinants of bone fragility are also determinants of cardiac dysfunction — a degree of overlap that far exceeds what most single-gene approaches would ever reveal.

Yet here the story takes an unexpected turn. Despite this extensive overlap, the genome-wide genetic correlation between the two diseases was weakly negative, at rg = −0.091 (standard error 0.024, P = 1.07 × 10⁻⁴). Moreover, when the researchers examined the correlation of effect sizes within the shared non-null component, they again found a negative value, rho_beta = −0.295. The interpretation is counterintuitive but biologically plausible: many of the same variants are involved in both conditions, but they frequently act in opposite directions. A variant that raises the risk of heart failure may, on average, lower the risk of osteoporosis, and vice versa. The diseases share their genetic machinery even as that machinery is tuned in opposing ways.

To move from global statistics to specific genomic locations, the team applied conditional and conjunctional false discovery rate (cond/conjFDR) analysis, a framework that borrows statistical strength across related traits to detect associations that neither dataset could confirm alone. This approach identified five pleiotropic loci — genomic regions harboring variants that influence both diseases — and, notably, three novel loci associated with heart failure that had not previously been flagged. The method’s power lies in its ability to elevate weak, sub-threshold signals to significance when they are corroborated across traits, effectively squeezing more discovery out of existing GWAS resources.

The next layer of analysis asked which genes, rather than which markers, the associations implicate. Through transcriptome-wide association studies (TWAS) conducted with the MetaXcan framework, the researchers imputed the genetic regulation of gene expression across tissues and tested whether genetically predicted expression levels associate with disease risk. They then cross-referenced these results with Bayesian colocalization methods — eCAVIAR and fastenloc — which test whether a GWAS signal and an expression quantitative trait locus (eQTL) signal in the same region are driven by the same causal variant rather than by two distinct variants in linkage disequilibrium. The consistent winner of this triangulation was HOXC6, a homeobox transcription factor gene prioritized as a shared transcriptomic candidate across multiple tissues. HOX genes are master regulators of developmental patterning, and their involvement in both a cardiovascular and a skeletal disorder hints at developmental programs that echo into adult disease susceptibility.

Perhaps the most novel component of the study is its spatial dimension. Using gsMap — genetically informed spatial mapping of cells for complex traits — the team projected human disease-associated genetic signals onto a reference atlas of single-cell spatial transcriptomics from E16.5 mouse embryos. This technique asks not just which genes are implicated, but in which anatomical niches their expression is concentrated. The results were strikingly compartmentalized: heart failure-associated genetic signals were enriched in embryonic muscle regions, consistent with the cardiac muscle as the affected tissue, while osteoporosis-associated signals concentrated in cartilage and cartilage-primordium regions, the developmental precursors of the skeletal system. Within this spatial framework, GRB10 emerged as a shared candidate gene. GRB10 is an adaptor protein in insulin-like growth factor signaling, a pathway with well-documented roles in growth, metabolism and tissue size regulation — making its dual appearance in heart and bone contexts a compelling lead for future work.

The authors are careful to frame these results as hypothesis-generating rather than definitive. The analyses rely on summary statistics and reference atlases, and the spatial mapping uses an embryonic mouse reference to interpret human adult disease, an approach that assumes developmental expression patterns illuminate disease-relevant biology. The negative genetic correlation also complicates any simple clinical translation: shared variants acting in opposite directions mean that a therapeutic strategy targeting a shared gene could, in principle, benefit one organ while harming the other. Precisely for that reason, the identification of candidates such as HOXC6 and GRB10 matters — they define concrete molecular entry points whose directionality and tissue context can now be tested experimentally in cellular and animal models.

What the study delivers is a new conceptual map of the heart–bone axis. It quantifies, for the first time at this resolution, just how extensively the genetic architectures of heart failure and osteoporosis interpenetrate, while simultaneously demonstrating that overlap does not equal concordance. The five pleiotropic loci, the three novel heart failure loci, the multi-tissue prioritization of HOXC6 and the spatially resolved nomination of GRB10 together generate a set of testable predictions about regulatory links between cardiovascular and skeletal traits. As the population ages and the clinical burden of both diseases grows, understanding the shared — and antagonistic — genetic wiring beneath them may prove essential for designing interventions that strengthen the heart without weakening the skeleton, and vice versa.

Subject of Research: Shared genetic architecture and spatial transcriptomic correlations between heart failure and osteoporosis

Article Title: Integrating multi-omics analysis reveals shared genetic architecture and spatial correlations between heart failure and osteoporosis

Article References: Integrating multi-omics analysis reveals shared genetic architecture and spatial correlations between heart failure and osteoporosis. (n.d.). https://doi.org/10.1038/s41598-026-74146-7

Image Credits: AI Generated

DOI: 10.1038/s41598-026-74146-7

Keywords: heart failure, osteoporosis, GWAS, polygenic overlap, MiXeR, TWAS, colocalization, HOXC6, GRB10, spatial transcriptomics, genetic correlation, pleiotropy

The research, led by Alexandros Rammos and Evie Stergiakouli at the University of Bristol together with colleagues at Cardiff University and the University of Exeter, drew on two of the United Kingdom’s most valuable population resources. The team analysed genetic and phenotypic data from 2,313 children with cleft lip and/or palate recruited through the Cleft Collective, the world’s largest cleft-specific cohort study, and compared them with 7,913 unaffected children from the Millennium Cohort Study, a nationally representative birth cohort. This scale matters, because questions about subtle genetic correlations demand thousands of participants before any signal can be distinguished from statistical noise.

The investigators deployed a battery of complementary genomic techniques, each probing a different aspect of the relationship between cleft biology and neurodevelopment. First, they used linkage disequilibrium score regression, a method that estimates the overall genetic correlation between two traits by examining whether the same stretches of the genome show association signals in both. If cleft liability and psychiatric conditions shared a common genetic architecture, this technique would detect it across hundreds of thousands of genetic variants simultaneously. Instead, the analysis revealed little evidence of genetic correlations between cleft lip and/or palate and any of the eight traits examined, which spanned cognitive, neurodevelopmental, and psychiatric domains.

Second, the team constructed polygenic risk scores for each child. These scores summarise the cumulative effect of thousands of common variants, each contributing a tiny amount, into a single number that estimates an individual’s inherited liability to a given trait. The researchers calculated scores for ADHD, autism, depression, anxiety, schizophrenia, bipolar disorder, educational attainment, and intelligence, and then asked two separate questions. Did children with clefts carry higher polygenic risk than controls? And within the cleft population, did polygenic scores predict actual developmental and behavioural outcomes measured through validated instruments such as the Strengths and Difficulties Questionnaire, the Ages and Stages Questionnaire, and the Moods and Feelings Questionnaire?

The results were revealing precisely because they diverged. Children with cleft lip and/or palate did not show elevated polygenic risk scores for any of the psychiatric or neurodevelopmental traits compared with population controls, nor lower scores for educational attainment or intelligence. Yet within the cleft group itself, the polygenic scores behaved exactly as they do in the general population: children with higher inherited liability to ADHD, for example, showed more ADHD-type behaviours, and children with higher educational attainment scores performed better developmentally. In other words, the genetic factors that shape neurodevelopment in children with clefts appear to be the same ones that shape it in everyone else, operating independently of cleft status rather than through a shared cleft-neurodevelopment pathway.

Third, the researchers turned to Mendelian randomization, a technique that exploits the random allocation of genetic variants at conception to test whether an exposure plausibly causes an outcome. Because genetic variants are inherited independently of the environmental and social confounders that plague observational research, they can serve as natural proxies. The team used genetic variants associated with cleft liability to ask whether genetic predisposition to clefts causally influences neurodevelopmental outcomes. The analysis provided no robust evidence that it does, further undermining the hypothesis that the cleft itself, through shared genetic roots, drives the increased rates of neurodevelopmental difficulty.

The study also examined the relationship between common and rare genetic variation, an area where prior findings had been much more positive. Previous work has established that rare neurodevelopmental copy number variants, large deletions or duplications of DNA segments that remove or multiply dozens of genes at once, are enriched among children with clefts and are associated with poorer developmental outcomes. If common and rare variants were acting through convergent biological pathways, one might expect children carrying these rare variants to also carry a heavier burden of common risk alleles. The team found no such difference: neurodevelopmental copy number variant carriers did not differ from non-carriers in their polygenic burden, suggesting the two classes of variation contribute independently.

The implications for clinical practice are significant. Because polygenic risk scores predict behavioural and developmental outcomes within the cleft population just as they do in the general population, these scores may retain clinical relevance for children with clefts, potentially helping to identify those who would benefit from early developmental monitoring and support. At the same time, the findings make clear that screening for clefts alone does not identify a population with elevated common variant liability to psychiatric illness. Clinicians and families should instead understand the increased neurodevelopmental risk in this group as arising from other sources, which may include the rare variants already identified, environmental exposures, perinatal complications, the social and surgical burdens associated with cleft care, or factors yet to be discovered.

The negative result also carries a broader lesson for psychiatric genetics. Comorbidities between apparently distinct conditions are often assumed to reflect shared genetic architecture, and in many cases that assumption holds. But this study demonstrates that a well-documented clinical association, between a major congenital malformation and neurodevelopmental difficulty, can exist without any detectable common genetic overlap. The mechanisms linking clefts to neurodevelopmental outcomes may be heterogeneous, involving rare mutations in some children, environmental and medical factors in others, and possibly the cumulative experience of living with a visible craniofacial difference and repeated surgical interventions. Disentangling these threads will require longitudinal data of the kind the Cleft Collective was designed to provide.

The research was funded by the Medical Research Council, with additional support from The Scar Free Foundation, The Underwood Trust, and the Vocational Training Charitable Trust, and it relied on the participation of thousands of families and the United Kingdom’s NHS cleft teams. By rigorously ruling out one of the most plausible genetic explanations for neurodevelopmental comorbidity in cleft lip and/or palate, the study sharpens the field’s focus on the mechanisms that remain. For the roughly one in seven hundred children born with an orofacial cleft, the message is cautiously reassuring: their inherited common genetic risk for psychiatric and cognitive difficulties looks much like anyone else’s, and the developmental challenges some of them face are not written into the same variants that shaped their cleft. Finding what does explain that risk is now the field’s central task.

Subject of Research: Common and rare genetic variant contributions to neurodevelopmental risk in children with orofacial clefts

Article Title: Common variant contributions to neurodevelopmental risk in orofacial clefts

Article References: Common variant contributions to neurodevelopmental risk in orofacial clefts. (n.d.). https://doi.org/10.1186/s12916-026-05171-6

Image Credits: AI Generated

DOI: 10.1186/s12916-026-05171-6

Keywords: orofacial clefts, cleft lip and palate, neurodevelopmental disorders, polygenic risk scores, Mendelian randomization, copy number variants, genetic correlation, ADHD, autism spectrum disorder, Cleft Collective, psychiatric genetics, BMC Medicine

The research, led by Eirik Haugland Kvalvik and colleagues including Yunpeng Wang, Kristine Beate Walhovd, Torkild Hovde Lyngstad, and Ole Røgeberg, drew on two extraordinary Norwegian data resources: the Norwegian Mother, Father and Child Cohort Study, known as MoBa, with 120,527 participants, and the Norwegian Twin Registry, contributing 8,910 individuals. Norway is an ideal setting for this kind of analysis because its education system is standardized and its registries are unusually complete. Rather than collapsing educational histories into a single number, the team treated each credential as its own event: finishing high school, earning a bachelor’s degree, completing a master’s, and reaching a doctorate. That reframing allowed them to ask a question the standard design cannot answer—do the genetic associations with education stay constant as people climb the ladder, or do they change from rung to rung?

The technical machinery behind the study combined three complementary approaches. First, the researchers ran genome-wide association studies, or GWAS, which scan hundreds of thousands of genetic variants for statistical links to each milestone. Second, they built polygenic indices, abbreviated PGIs, which condense the tiny effects of many variants into a single score for each individual and can be tested for how well they discriminate between people who do and do not reach a given milestone. Third, they applied twin models, which compare identical and fraternal twins to estimate heritability from family resemblance rather than measured DNA variants. Running all three on the same cohorts let the investigators cross-check their conclusions in ways no single method allows.

The headline finding is a striking inverse-U pattern. When the team analyzed each transition separately—conditioning on having reached the previous milestone—the heritability attributable to measured common genetic variants, known as SNP heritability, and the predictive power of the polygenic indices both rose and then fell across the educational sequence. The peak came at the transition from high-school completion to attaining at least a bachelor’s degree, where SNP heritability reached roughly 0.14 and the polygenic index achieved a Tjur R-squared of about 0.05, a measure of discrimination for binary outcomes. Beyond that point, at the postgraduate transitions, both measures declined. In other words, the genetic signal is strongest in the middle of the educational distribution and weakest at its very top.

That decline at the doctoral transition comes with an important statistical caveat that the authors are careful to flag. Estimates for the master’s-to-PhD transition were computed only among individuals who had already attained at least a master’s degree, a highly selected group. This creates range restriction: when nearly everyone in the analyzed sample shares the preceding credential, the variation available for genetic associations to explain is compressed, and attenuation of the estimates may partly reflect that selection rather than a genuine weakening of genetic influence. The study does not claim that genes stop mattering at the doctoral level; it claims that the standard interpretation of per-year effects cannot tell you what is happening there at all.

A second set of analyses probed how the genetics of education relate to the genetics of intelligence, a question that has long shadowed the field. The researchers computed genetic correlations between their milestone-specific results and large-scale GWAS of educational attainment and of intelligence. The pattern was clear: genetic overlap was high at earlier transitions but dropped at later ones. With the widely used EA4 educational attainment GWAS, the genetic correlation was approximately 0.92 at the transition from high school to a bachelor’s degree, but only about 0.38 at the transition from master’s to doctoral attainment. Sensitivity analyses using an alternative intelligence GWAS and additional polygenic indices reproduced the same transition-specific trajectories, suggesting the pattern is not an artifact of one particular reference panel or scoring method.

The twin data added a third perspective, and one of the study’s most surprising results. In cumulative analyses of attained status across the full cohort, the gap between twin-based heritability estimates and SNP-based estimates—the so-called missing heritability—shrank as the milestones became more advanced. At high-school completion, the point-estimate gap was roughly 0.38; at the doctoral level, it narrowed to about 0.11. This convergence challenges a common intuition that rare, hard-to-detect genetic variants must account for the missing heritability in complex traits. It suggests instead that part of the discrepancy in education research may arise from how the phenotype itself is constructed, with years-of-schooling scales blending together biological and social processes that behave differently at different points in the sequence.

Genetic correlations between the milestones themselves told a complementary story. Adjacent milestones—say, high-school completion and a bachelor’s degree—showed very high genetic overlap, around 0.92, indicating that largely the same set of variants is associated with both. But distant milestones were less genetically aligned: the correlation between high-school completion and a doctorate was approximately 0.71. The genetic architecture of education, in other words, is not a single unified target. Different stages of the educational career share much of their biology with their immediate neighbors while drifting apart from stages further away, a structure that a single years-based phenotype is mathematically incapable of expressing.

Why does this matter beyond the statistics? Years-of-education GWAS convert distinct credentials and progression steps into one numerical scale, and the resulting estimates are routinely reported as effects per additional year of schooling. The study’s central warning is that such estimates should not be read as though one year carries the same meaning across the entire educational sequence. A year that ends with a high-school diploma, a year in the middle of an undergraduate program, and a year of doctoral research are not interchangeable units of exposure; they sit at different points of a selective, staged process with different social and biological correlates. Polygenic indices built on the years-based phenotype inherit that ambiguity, which may explain why their predictive performance varies so sharply across the milestones examined here.

The practical implications reach into several active debates. For researchers using educational attainment as a proxy in studies of health, fertility, social mobility, or cognitive aging, milestone-preserving analyses offer a way to check whether conclusions depend on how the phenotype was coded. For geneticists, the results suggest that future GWAS of education could gain resolution by modeling transitions explicitly rather than pooling them. And for anyone interpreting polygenic scores in social science, the study is a reminder that a score’s predictive power is not a fixed property but a function of where on the educational ladder the question is being asked. By making the hidden structure of the years-based measure visible, the Norwegian team has sharpened the interpretation of education GWAS and polygenic indices alike—and shown that sometimes the most informative move in genetics is not to gather more data, but to look more carefully at the phenotype already in hand.

Subject of Research: Genetic associations with discrete educational milestones in Norwegian cohorts

Article Title: Beyond years of schooling: Genetic associations across educational milestones in two Norwegian cohorts

Article References: Kvalvik, E. H., Wang, Y., Walhovd, K. B., Lyngstad, T. H., & Røgeberg, O. (2026). Beyond years of schooling: Genetic associations across educational milestones in two Norwegian cohorts. PLOS Genetics, 22(9), e1012310. https://doi.org/10.1371/journal.pgen.1012310

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012310

Keywords: educational attainment, genetics, GWAS, polygenic indices, twin studies, heritability, Norway, MoBa, intelligence, doctoral attainment, SNP heritability, genetic correlation

The team approached the problem with two complementary technologies drawn from statistical genetics. The first was local genetic correlation analysis, carried out with a method called SUPERGNOVA, which estimates how strongly the genetic influences on two traits align or diverge within specific segments of the genome rather than averaging across all roughly three billion base pairs. The researchers applied this tool to sixteen specific cancers plus a pan-cancer phenotype, computing pairwise local correlations for every combination. The second approach relied on polygenic risk scores, or PRSs, which condense the small effects of hundreds of thousands of common genetic variants into a single number estimating an individual’s inherited liability to a disease. By testing whether a PRS built for one cancer predicted risk of another, the researchers could ask whether shared susceptibility extends from broad genomic architecture down to the level of actual prediction.

The genome-wide results set the stage for everything that followed. When the authors computed standard genome-wide genetic correlations across all cancer pairs, they found twenty significantly correlated pairs, a number that confirms earlier reports of modest pan-cancer sharing but also underscores how much of the genome’s influence on each cancer remains disease-specific. Genetic correlation at this scale is a blunt instrument: it asks whether the constellation of variants affecting one cancer tends, on average, to affect another in the same direction. A weak overall correlation does not mean the two cancers share nothing; it may simply mean that shared effects concentrated in a handful of genomic neighborhoods are diluted by thousands of variants acting independently.

That is precisely what the local analysis revealed. Zooming into genomic regions rather than whole chromosomes, Hu and colleagues identified eighty-two distinct regions where genetic signals were shared across sixty-six different cancer pairs. In other words, the number of cancer pairs showing evidence of shared genetic influence more than tripled once the analysis moved from the genome-wide to the regional scale. These regions are not random stretches of DNA. The team annotated them using genetic correlations with non-cancer traits and known associations catalogued in the GWAS Catalog, building a functional picture of where and why cancer susceptibilities converge.

Among the eighty-two shared regions, five stood out as hubs of what the authors call mutually correlated cancer clusters. In these locations, the local genetic effects on multiple cancers were correlated with one another in a structured web, rather than in isolated pairs. When the researchers examined what these hub regions do biologically, enrichment appeared in functional domains connected to inflammatory processes. The finding fits a broader theme in cancer genetics: chronic inflammation is a recognized driver of tumor initiation and progression in many tissues, and inherited variation in immune and inflammatory regulation could plausibly tilt risk for several cancers at once. A single regulatory variant that dampens or amplifies inflammatory signaling, for example, might leave detectable fingerprints in the genetic architecture of lung, colorectal, and other inflammation-associated malignancies simultaneously.

The polygenic risk score analysis added an independent line of evidence. Testing PRSs across cancer pairs, the researchers identified five pairs of cancers with statistically significant cross-cancer associations, meaning that a genetic risk score optimized for one cancer carried predictive information for the other. This is a meaningful step beyond correlation of summary statistics, because PRS association tests whether shared genetic liability is strong enough to translate into measurable prediction in independent data. Still, five significant pairs out of the many tested reinforces the study’s headline conclusion: cross-cancer prediction from genetics exists, but it is the exception rather than the rule, and it demands careful dissection before it can be interpreted biologically.

That dissection came from the study’s most technically inventive component, the decomposition of genome-wide PRSs into functionally informed components. Rather than treating a PRS as an indivisible number, the authors split it into pleiotropy-informed parts, which emphasize variants already known to influence multiple traits, and pathway-specific parts, which weight variants according to membership in defined biological pathways. When the significant cross-cancer PRS associations were decomposed this way, a clear pattern emerged: the shared predictive signal was concentrated in specific pleiotropy groups and in immune-related pathways, not spread diffusely across the genome. The cross-cancer associations, in other words, are not a generic reflection of genetic overlap between complex traits; they trace back to identifiable biological machinery.

The immune pathway enrichment ties the two analytical strands of the study together elegantly. The regional analysis pointed to inflammatory functional domains in the hub regions of shared local genetic correlation, and the PRS decomposition pointed to immune-related pathways as carriers of cross-cancer predictive signal. Two independent methods, operating at different scales of genomic resolution, converged on the same biological story. This kind of methodological triangulation matters in a field where pleiotropy, the phenomenon of one variant influencing many traits, can arise from genuine shared biology or from statistical artifacts such as sample overlap and population stratification. Agreement between local correlation and PRS-based prediction makes a genuine biological basis for the shared risk considerably more convincing.

The implications reach into both research practice and, eventually, clinical risk assessment. For researchers, the study supplies a framework: rather than asking only whether two cancers are genetically correlated overall, investigators can map where in the genome the correlation lives, which functional categories those regions implicate, and whether the shared signal is strong enough to survive PRS-based prediction testing. For clinicians and genetic counselors, the work tempers expectations while pointing to future opportunities. Current polygenic risk scores are largely cancer-specific, and the modest number of significant cross-cancer pairs suggests that a single pan-cancer score is not on the immediate horizon. But for the specific pairs identified, particularly those anchored in immune pathways, multi-cancer risk models that borrow strength across related malignancies could eventually sharpen risk stratification, especially as PRS methods improve and datasets grow more diverse.

The study also carries a cautionary note about scale. Findings that vanish at the genome-wide level but appear at the regional level illustrate a general principle in complex-trait genetics: aggregation can obscure as much as it reveals. Eighty-two shared regions hiding inside twenty significant genome-wide correlations is a quantitative demonstration that the architecture of shared disease risk is heterogeneous, concentrated in pockets of the genome where pleiotropic variants cluster. As biobank-scale datasets expand and methods like SUPERGNOVA and PRS decomposition mature, the expectation is that more of these hidden threads connecting cancers will come into view, each one a potential clue to mechanisms that tumor types as different as melanoma and leukemia might, unexpectedly, share. For now, Hu and colleagues have shown that the genetic conversation between cancers is quieter than a pan-cancer model would hope, but far more organized than a genome-wide average would suggest.

Subject of Research: Shared polygenic genetic risk across multiple cancer types

Article Title: Identifying shared polygenic risk across cancers

Article References: Hu, J., Muheyati, M., Xu, L., DeWan, A., & Zhao, H. (2026). Identifying shared polygenic risk across cancers. PLOS Genetics, 22(9), e1012308. https://doi.org/10.1371/journal.pgen.1012308

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012308

Keywords: polygenic risk scores, genetic correlation, cancer genetics, pleiotropy, SUPERGNOVA, immune pathways, inflammation, GWAS, cross-cancer susceptibility, genomic regions, PLOS Genetics, risk prediction

The team’s central tool was genomic structural equation modeling, a statistical framework that allows researchers to work with latent factors, meaning unobserved variables that summarize the genetic overlap among groups of related conditions. Instead of asking whether, say, rheumatoid arthritis is genetically correlated with depression in isolation, the investigators first organized the immune-mediated diseases into latent factors such as an overall autoimmune liability, and organized psychiatric disorders into latent factors such as an internalizing dimension that captures shared genetic risk across depression, anxiety, and related conditions. This approach mirrors how clinical reality actually presents: patients rarely carry a single diagnosis, and genetic risk similarly clusters across diagnostic boundaries. By modeling these clusters, the study could ask a more powerful question than pairwise correlations allow.

That question was whether the genetic liability for specific immune markers, circulating in measurable quantities in the blood, statistically mediates the relationship between the immune disease factors and the psychiatric disorder factors. Mediation, in this context, means that part of the genetic correlation between two clusters of illness flows through a third variable. The fourteen markers examined included some of the most intensively studied molecules in psychoneuroimmunology, among them C-reactive protein, universally measured in clinical settings as a marker of systemic inflammation, and interleukin-6, a signaling molecule of the immune system that stimulates the liver to produce C-reactive protein in the first place. Other markers spanned additional branches of immune signaling, giving the analysis coverage of multiple biological pathways rather than a single inflammatory axis.

The headline finding is a striking correction to a widely repeated narrative. C-reactive protein has been described extensively in the literature as psychiatrically relevant, with elevated levels repeatedly linked to depression and other conditions in large cohort studies. But when the researchers accounted for the overlapping genetic signal with interleukin-6, the associations between psychiatric traits and C-reactive protein were highly attenuated, essentially shrinking toward zero. In other words, the psychiatric relevance long attributed to C-reactive protein appears to be better explained by its biological precursor. Because interleukin-6 sits upstream, driving the production of C-reactive protein, this reframing matters enormously for how researchers interpret inflammation measurements in psychiatry. A blood test result that looks like a C-reactive protein story may in fact be an interleukin-6 story wearing a different label.

Across the full set of analyses, the genetic liability of six immune markers significantly mediated eleven distinct psychiatric-immune disease genetic relationships. The magnitude of some of these mediated effects was remarkable. Interleukin-6 alone mediated roughly sixty percent of the genetic link between the latent internalizing factor and Crohn’s disease, an inflammatory bowel condition. That means a majority of the shared genetic architecture between a cluster of mood and anxiety related disorders and a chronic gut inflammation disease appears to travel through variation in circulating levels of a single immune signaling molecule. For a field that has often spoken in generalities about inflammation and mental health, this is the kind of quantitative specificity that can redirect research programs.

Equally informative was the pattern of the mediation effects. The identified markers did not behave as narrow, one-to-one bridges between a single immune disease and a single psychiatric diagnosis. Instead, many of the significant markers showed mediating effects across multiple disorder clusters, and many individual immune-psychiatric relationships were mediated by more than one marker. This suggests a network-like architecture in which a small set of circulating immune molecules serves as a shared conduit connecting diverse forms of physical and mental illness. At the same time, the study’s diagnostic relevance comes from what it excluded: only a subset of the fourteen examined markers emerged as significant mediators. The immune system produces hundreds of measurable proteins, and this analysis indicates that the psychiatric-immune connection is not diffuse noise across all of them but concentrated in a specific, identifiable handful.

The technical machinery behind these conclusions deserves attention, because genetic mediation studies are easy to get wrong. Genomic structural equation modeling combines genome-wide association study summary statistics, which estimate the genetic contribution to each trait from hundreds of thousands of genetic variants across large populations, into models that can test whether correlations between traits are consistent with an underlying causal pathway. Because the method works with summary statistics rather than individual patient data, it can integrate enormous samples from separate consortia studying immune diseases, psychiatric disorders, and blood biomarkers. The mediation tests then ask whether the genetic correlation between, for example, the autoimmune factor and the internalizing factor diminishes once the genetic variance shared with interleukin-6 levels is statistically accounted for. A substantial reduction indicates that the marker carries a meaningful share of the relationship.

What makes this mechanistic framing biologically plausible is the established physiology of the molecules involved. Interleukin-6 is a cytokine released by immune cells during inflammation, and it crosses into and signals within the central nervous system, where it can influence neurotransmitter metabolism, neural circuit function, and behavior. C-reactive protein, produced by the liver under interleukin-6 stimulation, is generally viewed as a downstream readout of inflammatory activity rather than an active driver. The study’s statistical results align neatly with this biology: the upstream signaling molecule, not the downstream readout, carries the genetic relationship to psychiatric liability. This convergence between statistical mediation and known molecular pathways strengthens the case that the findings reflect genuine biology rather than statistical artifact.

The clinical implications are considerable, though the authors’ findings are genetic and mediational, not proof of causation in individual patients. If a substantial fraction of the genetic overlap between immune diseases and psychiatric disorders flows through a small set of immune markers, then those markers become prime candidates for intervention studies, biomarker development, and patient stratification. A patient with Crohn’s disease and elevated interleukin-6 might represent a distinct subgroup whose psychiatric risk is mechanistically tied to their inflammatory disease, potentially warranting closer monitoring or treatments that target the shared pathway. Conversely, the finding that C-reactive protein is not itself a significant mediator cautions against continuing to treat it as the default inflammatory biomarker in psychiatric research, a practice the authors’ results suggest may have been tracking the wrong molecule.

More broadly, the study exemplifies a shift in how genetics is being used to dissect the architecture of comorbidity. Rather than cataloging correlations and stopping there, methods like genomic structural equation modeling allow researchers to propose and test specific mechanistic hypotheses about how genetic liabilities travel between organ systems. The immune system and the brain have long been studied by separate communities with separate journals, separate conferences, and separate vocabularies. Findings like these, which pinpoint interleukin-6 and five other markers as the molecular bridges linking eleven immune diseases to thirteen psychiatric disorders, provide a common quantitative language for both. The work does not close the book on the immune-psychiatric connection, but it does something arguably more valuable: it tells researchers exactly which pages to read next, and which molecules to watch when the story of body and mind continues to unfold.

Subject of Research: Genetic mediation of relationships between immune-mediated diseases and psychiatric disorders by circulating immune markers

Article Title: Immune markers mediate genetic relationships between immune diseases and psychiatric disorders

Article References: Breunig, S., Kelly, K. M., Schaffer, L. S., Lawrence, J. M., Lee, Y. H., Karlson, E. W., & Grotzinger, A. D. (2026). Immune markers mediate genetic relationships between immune diseases and psychiatric disorders. PLOS Genetics, 22(9), e1012328. https://doi.org/10.1371/journal.pgen.1012328

Image Credits: AI Generated

DOI: 10.1371/journal.pgen.1012328

Keywords: genomic structural equation modeling, interleukin-6, C-reactive protein, immune-mediated diseases, psychiatric disorders, genetic correlation, mediation analysis, Crohn's disease, internalizing disorders, inflammation, GWAS, psychoneuroimmunology

The study, published in BMC Genomics, took advantage of the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be, known as nuMoM2b, a multi-center prospective cohort that collected biospecimens in early pregnancy, genome-wide genotype data, and detailed clinical outcomes across multiple ancestry groups. Led by researchers at Indiana University and collaborators across the United States, the team performed genome-wide association studies of first-trimester CRP levels using maternal genotypes from 4,326 participants and offspring genotypes from 2,140 children. The design allowed them to ask two distinct questions at once: which parts of the genome influence CRP levels during early pregnancy, and whether the inherited propensity toward higher or lower CRP translates into a measurable shift in gestational diabetes risk.

The first answer came cleanly. In the European-ancestry maternal sub-cohort, the researchers identified three genome-wide significant loci associated with early-pregnancy CRP levels: the CRP gene itself, LEPR, which encodes the leptin receptor, and HNF1A, a transcription factor with a well-documented role in regulating hepatic CRP production. These findings align closely with what large GWAS in non-pregnant populations have reported, indicating that the fundamental genetic architecture of CRP regulation persists into pregnancy. That consistency matters, because it suggests the pregnancy state does not wholesale rewrite the genetic control of this inflammatory marker, even though pregnancy itself dramatically reshapes inflammatory physiology.

When the analysis was widened to the full multi-ancestry maternal cohort, two additional loci emerged: ENSG00000257703 and APOC1. The appearance of ancestry-informative signals underscores a recurring theme in human genomics: cohorts that concentrate on a single ancestry group miss variants that are common or consequential elsewhere. APOC1, involved in lipid metabolism, sits in a genomic region long known to influence CRP, and its detection here hints at connections between inflammatory and metabolic pathways that pregnancy may bring into sharper focus. By contrast, the offspring GWAS of CRP levels produced no genome-wide significant associations at all, a null result the authors interpret in light of the smaller sample size and the distinct biology of fetal and neonatal CRP regulation.

The more provocative part of the study concerns gestational diabetes. Using linkage disequilibrium score regression, a technique that estimates the genetic correlation between traits from summary statistics alone, the team found no significant genetic correlation between CRP and gestational diabetes when using the nuMoM2b CRP GWAS as the input. That absence of correlation would seem to close the door on the idea that genetically influenced CRP levels meaningfully shape GDM risk. But the picture grew more complicated: when the researchers substituted an external, much larger population-based CRP GWAS, a significant genetic correlation with gestational diabetes did appear.

That discrepancy is not a contradiction so much as a lesson in how context shapes genomic inference. Genetic correlations estimated from summary statistics can vary depending on the population studied, the environment in which the phenotype was measured, and the specific covariates and ascertainment of each cohort. A CRP GWAS measured in early pregnancy among nulliparous women captures a different biological moment than one measured in the general adult population, where inflammation reflects age, adiposity, infection history, and chronic disease. The authors suggest that the genetic overlap between CRP and gestational diabetes may therefore vary across study contexts, a caution that extends well beyond this particular pair of traits.

To probe the relationship more directly, the team constructed polygenic risk scores for CRP, aggregating the small effects of thousands of variants into a single inherited score per individual, and tested whether those scores predicted gestational diabetes in the nuMoM2b cohort. They did not, regardless of whether the scores were derived from the pregnancy-specific GWAS or from the external population-based one. In other words, even where a statistical genetic correlation could be detected at the level of populations, the aggregate inherited influence on CRP was not a useful predictor of who would develop gestational diabetes within this cohort. The polygenic signal, the study concludes, is limited.

For clinicians and researchers, the result is a sobering check on a tempting hypothesis. Elevated CRP in early pregnancy is associated with later gestational diabetes in observational studies, and it has been natural to wonder whether inflammation is part of the causal chain. This work indicates that the genetic component of CRP variation, at least as it can currently be measured, contributes little to that association. If CRP and gestational diabetes are connected, the link is more likely mediated by environmental factors, adiposity, insulin resistance, or the hormonal shifts of pregnancy than by inherited differences in inflammatory set-point. Genetic risk prediction for gestational diabetes will need to look elsewhere, most plausibly toward the substantial polygenic architecture of glycemic traits themselves.

The study also carries a broader methodological message. Pregnancy-specific genomic resources remain scarce relative to their clinical importance, and this analysis demonstrates both their value and their limits. The nuMoM2b cohort, with thousands of well-phenotyped pregnancies and paired maternal-offspring genotypes, was large enough to replicate known CRP loci and to detect new ones in a multi-ancestry framework, yet the authors are explicit that larger pregnancy cohorts are needed to fully untangle the relationship between inflammation and metabolic complications of pregnancy. Gestational diabetes affects millions of pregnancies worldwide each year, and its long-term sequelae, including elevated lifetime risk of type 2 diabetes in mothers and altered metabolic programming in offspring, make it a priority target for precision approaches.

What emerges from this work is a carefully bounded conclusion rather than a dramatic one. The genetic architecture of CRP in early pregnancy mirrors what has been mapped in non-pregnant populations, with CRP, LEPR, and HNF1A as anchor points and APOC1 and one additional locus joining the map in a multi-ancestry analysis. Offspring CRP genetics yielded no significant signals. Genetic correlation with gestational diabetes appears only under some analytic conditions and not others, and polygenic risk scores for CRP fail to predict the disease. In an era when inflammatory biomarkers are frequently proposed as early warning signs of pregnancy complications, the study offers a useful corrective: a biomarker can travel with a disease without its genes being responsible for it, and disentangling the two requires cohorts, ancestries, and analytic frameworks designed specifically for the biology of pregnancy.

Subject of Research: Genome-wide association study of C-reactive protein levels in pregnancy and its polygenic relationship with gestational diabetes mellitus

Article Title: Maternal and offspring genome-wide association study of C-reactive protein reveals limited polygenic association with gestational diabetes mellitus

Article References: Zhang, Y., Moore, A., Ryckman, K. K., Yan, Q., Guerrero, R. F., Li, M., Silver, R. M., Luo, J., Yee, L. M., Reddy, U. M., Feghali, M. N., Chung, J., Haas, D. M., Kua, K. L., & Liu, N. (2026). Maternal and offspring genome-wide association study of C-reactive protein reveals limited polygenic association with gestational diabetes mellitus. BMC Genomics, 27(1), Article 782. https://doi.org/10.1186/s12864-026-12878-6

Image Credits: AI Generated

DOI: 10.1186/s12864-026-12878-6

Keywords: C-reactive protein, gestational diabetes, GWAS, polygenic risk score, nuMoM2b, pregnancy, inflammation, genetic correlation, LEPR, HNF1A, APOC1, maternal-fetal health

The research, led by a team at Peking University working with the Chinese National Twin Registry, took a two-pronged approach. On one side, the investigators analyzed twin data from 2,548 individuals, comparing identical twins, who share essentially all of their DNA, with fraternal twins, who share roughly half. On the other side, they mined GWAS summary statistics from more than 92,615 participants in Asian cohorts. By estimating heritability through both classical twin modeling and modern SNP-based methods, they could directly compare the two traditions and quantify exactly where the numbers diverge.

The traits under scrutiny were ten of the most clinically important cardiometabolic measures: body mass index (BMI), waist-to-hip ratio (WHR), hemoglobin A1c (HbA1c), fasting blood glucose (FBG), systolic and diastolic blood pressure (SBP and DBP), total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C). Together, these markers capture the biological landscape of obesity, glucose metabolism, blood pressure regulation, and blood lipid profiles—the very factors that drive the world’s leading causes of death.

The headline result is striking. Twin-based analyses yielded moderate to high heritability estimates, ranging from 0.34 to 0.72 across the ten traits, meaning that between a third and nearly three-quarters of the variation in these measures could be attributed to genetic differences. GWAS-based estimates, by contrast, came in far lower, between 0.10 and 0.22. This confirms, in an Asian population, the same pattern long observed in European cohorts: twin studies see more heritability than GWAS can account for, leaving a substantial residue that must be explained by other mechanisms.

One leading candidate for the missing heritability has been non-additive genetic effects—particularly dominance effects, where the combined action of two alleles at a locus produces an effect that simple additive models cannot capture. To test this, the team built structural equation models that decompose trait variance into additive genetic, dominance genetic, shared environmental, and unique environmental components. The verdict was unambiguous: dominance genetic variance was statistically significant only for BMI, with an estimated dominance component of 0.42, and no evidence of non-additive effects appeared anywhere in the GWAS summary statistics. For most cardiometabolic traits, the dominant role of simple additive inheritance stands, and the missing heritability cannot be pinned on gene-gene interactions of this kind.

That leaves gene-environment interactions as a prime suspect, and here the study delivered some of its most intriguing findings. Using variance components models that allow genetic and environmental influences to vary across levels of environmental exposures, the researchers identified twelve small but statistically significant interaction effects. These involved age, smoking, alcohol consumption, education, and mental health status—factors that modulate how strongly genetic variants express themselves in measurable traits. In other words, the same set of genes may push blood pressure or blood sugar to different degrees depending on whether a person smokes, drinks, has reached a certain age, or carries psychological stress. The effect sizes were modest, but the pattern is consistent with the idea that genes and environment do not operate in separate silos; they collaborate, and that collaboration quietly shapes the heritability we observe.

The study also mapped the genetic correlations between pairs of cardiometabolic traits, asking whether the same genes influence more than one measure. The answers ranged from low to high, spanning 0.09 to 0.90, and—crucially—the patterns estimated from twin data broadly matched those derived from GWAS. This convergence matters. It suggests that the discrepancy between twin and GWAS heritability estimates does not reflect fundamentally different genetic pictures, but rather differences in what each method can detect. Twin models capture all inherited variation, including rare variants and effects in genomic regions poorly tagged by genotyping arrays, while GWAS-based estimates reflect only the additive effects of common SNPs that are well captured in the data.

There is also a broader significance to the population in which this work was conducted. The vast majority of large-scale genetic studies have been performed in populations of European ancestry, and researchers have warned repeatedly that findings from these studies do not always translate to other groups. Differences in allele frequencies, linkage disequilibrium patterns, and environmental contexts can all alter how genetic risk manifests. By grounding both the twin analyses and the GWAS heritability estimates in Asian populations, this study helps close a critical gap in the global picture of cardiometabolic genetics, providing evidence that the fundamental genetic architecture—high twin heritability, modest SNP heritability, minimal dominance, and pervasive gene-environment interplay—holds across ancestries.

Methodologically, the work is a showcase of integration. The twin component relied on classical structural equation modeling of monozygotic and dizygotic pairs, with zygosity confirmed through questionnaire-based assessment validated by methylation array data. The GWAS component drew on publicly available summary statistics from Asian cohorts, applying SNP-based heritability methods that estimate the variance explained by common variants through their correlations with the trait. By running both approaches on the same ten traits and comparing their outputs side by side, the team created a natural experiment in which each method could serve as a check and complement to the other.

For clinicians and public health researchers, the implications are tangible. The confirmation that BMI carries a substantial dominance component suggests that some obesity risk is inherited in ways that current additive polygenic models may underrepresent, potentially affecting the accuracy of genetic risk scores. The dozen identified gene-environment interactions point to modifiable levers—smoking cessation, alcohol moderation, mental health support, and attention to age-related changes—that could blunt genetic susceptibility. And the finding that genetic correlations between cardiometabolic traits are broadly consistent across methods strengthens confidence that pleiotropy, the phenomenon of one gene influencing multiple traits, is real and quantifiable. As the era of precision medicine accelerates, studies like this one provide the calibrated foundation on which genetic prediction, prevention, and treatment strategies must ultimately rest. The mystery of missing heritability is not solved in a single paper, but by systematically ruling out dominance effects, spotlighting gene-environment interactions, and demonstrating cross-method consistency in an understudied population, this work takes a substantial and welcome step toward that goal.

Subject of Research: Estimation of heritability and gene-environment interactions for cardiometabolic traits by integrating twin and GWAS data in Asian populations

Article Title: Revealing genetic foundations underlying cardiometabolic traits: integrating twin and GWAS data in Asian populations

Article References: Hong, X., Li, M., Cao, W., Lv, J., Yu, C., Huang, T., Sun, D., Liao, C., Pang, Y., Hu, R., Gao, R., Yu, M., Zhou, J., Wu, X., Liu, Y., Yin, S., Gao, W., & Li, L. (2026). Revealing genetic foundations underlying cardiometabolic traits: integrating twin and GWAS data in Asian populations. International Journal of Obesity. https://doi.org/10.1038/s41366-026-02209-w

Image Credits: AI Generated

DOI: 10.1038/s41366-026-02209-w

Keywords: heritability, twin study, GWAS, cardiometabolic traits, missing heritability, gene-environment interaction, BMI, blood pressure, lipids, genetic correlation, Chinese National Twin Registry, Asian populations

The research, conducted by Chang S. Han of Kyung Hee University and LMU Munich, Cristina Tuni of LMU Munich and the University of Turin, and Niels J. Dingemanse of the University of Turin, focused on male two-spotted field crickets, Gryllus bimaculatus, drawn from a pedigreed laboratory population. The pedigree is crucial. Because the relatedness of every individual in the population is known, the researchers could apply quantitative genetic techniques, including animal model analyses, to separate the genetic contribution to behaviour from environmental effects. This allowed them to ask not merely whether the correlation between aggression and exploration declines with age, but whether the genetic underpinning of that correlation does too, and if so, why.

The behaviours in question are staples of personality research. Aggression was measured through staged contests in which males fought one another, with researchers scoring the intensity and outcome of each interaction. Exploration was assessed by observing how readily individuals moved through and investigated novel environments. Both are labile traits, meaning they can change from moment to moment, yet individuals differ consistently from one another in their typical expression. In this population, more aggressive males also tended to be more exploratory, producing a positive among-individual correlation of the kind documented across fishes, birds, mammals and insects, and central to the pace-of-life syndrome framework, which links behavioural types to differences in growth, reproduction and lifespan.

The study’s central finding is that this positive correlation, robust across the nymphal and young adult stages, steadily eroded as males aged through adulthood. At first glance, this pattern might suggest a simple developmental story: perhaps the developmental processes that synchronise aggression and exploration early in life simply dissolve over time. But the quantitative genetic analysis revealed something more intricate. The genetic correlation between the two behaviours, an estimate of the extent to which the same genes influence both traits, followed a parallel trajectory, remaining strong in early stages and weakening significantly in older adults. Crucially, the researchers found no evidence that short-term permanent environmental correlations were responsible for the observed age-related change. The similarity between the among-individual and genetic patterns pointed instead to causes operating at the level of genes and selection.

The first such cause is survival selection, a form of natural selection in which an individual’s phenotype determines whether it lives long enough to appear in the older age classes. In this population, selection at the young adult stage tended to favour less explorative males, meaning that highly exploratory individuals were disproportionately likely to die before reaching later ages. Because exploration was genetically linked to aggression, the selective removal of certain exploratory genotypes dragged the aggression-exploration correlation along with it. As the composition of surviving genotypes shifted with age, the tight coupling between the two behaviours weakened. This is a mechanism familiar from evolutionary genetics: selection on one trait can reshape the genetic architecture of correlated traits, and when selection is age-specific, that reshaping unfolds along the lifespan.

The second mechanism is arguably more surprising: genetic variation in age-related behavioural plasticity, sometimes described through genotype-by-age interactions. Different genotypes, the researchers found, do not all change their exploratory behaviour at the same rate as they age. Some genotypes maintain high exploration into old age, while others decline earlier or follow entirely different trajectories. This heritable variation in the age-specific expression of exploration meant that the genetic relationships among individuals were not fixed across the lifespan. As genotypes diverged in their ageing patterns, the genetic correlation between aggression and exploration diminished, independently of whether any individual survived or died. In other words, the genetic architecture of behaviour is itself dynamic, and genes that bind two traits together at one age may loosen their grip at another.

The significance of these findings extends well beyond crickets. Behavioural syndromes are widely regarded as evolutionary constraints: when the same genes influence multiple traits, selection cannot freely optimise one trait without dragging the other along. This idea has been formalised in models showing that behavioural correlations can slow or redirect adaptive evolution, and empirical work in wild birds, marmots, fishes and insects has repeatedly documented heritable correlations among personality traits. Yet most such studies capture a snapshot, typically of adult animals of unspecified or unremarked age. The new results warn that such snapshots may be misleading. A genetic correlation measured in young adults may overstate the constraint operating in older individuals, and predictions of evolutionary response that ignore age structure may therefore be systematically wrong.

The study also connects to a broader literature on the evolutionary genetics of ageing. Research on wild passerine birds, swans, houbara bustards and other organisms has shown that genetic variances and covariances of traits can change with age, consistent with theoretical predictions from mutation-accumulation and antagonistic pleiotropy theories of senescence. Previous work, including studies reporting that strong genetic correlations underlying behavioural syndromes disappear during development through genotype-age interactions, hinted at the kind of dynamics now documented in crickets. What distinguishes the new research is its explicit attempt to weigh competing mechanisms against one another within a single pedigreed population. By jointly estimating genetic correlations, age-related plasticity and survival selection, the authors demonstrated that age-related change in behavioural architecture is a multi-causal phenomenon, produced by both the selective sorting of genotypes and the age-dependent expression of behaviour within genotypes.

For evolutionary biologists, the practical message is that age must enter the models. Quantitative geneticists have developed powerful tools, notably the animal model, to partition phenotypic variance into additive genetic and environmental components, and these tools can now be extended to ask how the entire genetic covariance matrix, often abbreviated as the G-matrix, transforms across the lifespan. The cricket results suggest that the G-matrix is not a static property of a population but a moving target, reshaped continuously by mortality and by the plastic, genotype-specific unfolding of behaviour over time. Studies of morphological integration and developmental modularity have made similar arguments for structural traits; this work brings labile behavioural traits squarely into that conversation.

For anyone who has watched a young animal grow calmer, slower or more predictable with age, the findings offer a mechanistic explanation grounded in genetics and selection. The personalities we observe are not engraved once at birth and fixed forever; they are the output of genes whose effects shift as organisms age, filtered by the unforgiving arithmetic of survival. As highly exploratory crickets are weeded out and as different genotypes age along different behavioural paths, the once-tight bonds between boldness and aggression loosen. What looks like the mellowing of old age is, at the genetic level, a population’s architecture being rewritten. Understanding that rewriting, the authors argue, is essential if we hope to predict how animal populations will respond to selection in a changing world, one behavioural correlation at a time.

Subject of Research: Age-related changes in genetic correlations between aggression and exploration in male field crickets

Article Title: Selection and genetic variation in age-related plasticity drive the erosion of among-individual behavioural correlations in later life

Article References: Han, C. S., Tuni, C., & Dingemanse, N. J. (2026). Selection and genetic variation in age-related plasticity drive the erosion of among-individual behavioural correlations in later life. Heredity. https://doi.org/10.1038/s41437-026-00884-z

Image Credits: AI Generated

DOI: 10.1038/s41437-026-00884-z

Keywords: behavioural syndromes, animal personality, genetic correlation, age-related plasticity, survival selection, genotype-by-age interactions, quantitative genetics, field crickets, Gryllus bimaculatus, pace-of-life syndrome, aggression, exploration